NCT03423290View on ClinicalTrials.gov

Safety and Efficacy Analysis of FRED™/FRED™Jr Embolic Device in Aneurysm Treatment

CompletedOBSERVATIONAL
Enrollment

61

Participants

Timeline

Start Date

November 23, 2017

Primary Completion Date

September 30, 2021

Study Completion Date

January 26, 2022

Conditions
Intracranial Aneurysm
Interventions
DEVICE

FRED and FRED Jr

Flow Re-Direction Endoluminal Device

Trial Locations (7)

B15 2TH

University Hospital Birmingham, Birmingham

BN2 5BE

Brighton & Sussex Universitys Hospitals, Brighton

EH4 2XU

Western General Hospital - NHS Lothian, Edinburgh

L97 LJ

The Walton Centre NHS Foundation Trust, Liverpool

W6 8RF

Imperial College Healthcare NHS Trust, London

NE7 7DN

The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne

ST4 6QG

University Hospitals of North Midlands NHS Trust, Stoke-on-Trent

Sponsors

Collaborators (1)

Clinact
All Listed Sponsors
collaborator

Clinact

OTHER

lead

Microvention-Terumo, Inc.

INDUSTRY

NCT03423290 - Safety and Efficacy Analysis of FRED™/FRED™Jr Embolic Device in Aneurysm Treatment | Biotech Hunter | Biotech Hunter